SUNTEREX Trademark

Trademark Overview

On Monday, August 14, 2017, a trademark application was filed for SUNTEREX with the United States Patent and Trademark Office. The USPTO has given the SUNTEREX trademark a serial number of 87568693. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 13, 2021. This trademark is owned by Sunovion Pharmaceuticals Inc.. The SUNTEREX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder; pharmaceutical preparations for treating eating disorders
sunterex

General Information

Serial Number87568693
Word MarkSUNTEREX
Filing DateMonday, August 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder; pharmaceutical preparations for treating eating disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Monday, September 13, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 13, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, February 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2021EXTENSION 5 GRANTED
Friday, February 5, 2021EXTENSION 5 FILED
Thursday, February 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 5, 2021TEAS EXTENSION RECEIVED
Thursday, January 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 6, 2020EXTENSION 4 GRANTED
Thursday, August 6, 2020EXTENSION 4 FILED
Thursday, August 6, 2020TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 7, 2020EXTENSION 3 GRANTED
Friday, February 7, 2020EXTENSION 3 FILED
Friday, February 7, 2020TEAS EXTENSION RECEIVED
Friday, August 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2019EXTENSION 2 GRANTED
Wednesday, August 7, 2019EXTENSION 2 FILED
Wednesday, August 7, 2019TEAS EXTENSION RECEIVED
Friday, February 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2019EXTENSION 1 GRANTED
Wednesday, February 6, 2019EXTENSION 1 FILED
Wednesday, February 6, 2019TEAS EXTENSION RECEIVED
Tuesday, August 7, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 28, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, January 18, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2017ASSIGNED TO EXAMINER
Monday, August 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

sunterex pharmaceutical treating preparations disorders hyperactivity eating deficit disorder diseases central